Tag Archives: Xifaxan

Valeant to keep Salix after Takeda deal blows up; it’s déjà vu all over again

Valeant Pharmaceuticals International Inc.’s (Laval Québec) talks to sell a stomach-drug business to Japan’s Takeda Pharmaceutical Co. (Osaka) for roughly $10 billion have broken down amid last-minute disagreements over price and other matters,… Read more »

Needing cash, Valeant in talks to sell stomach-drug unit in $10 billion deal; hedge-fund icon Bill Ackman finally has a good day

Valeant Pharmaceuticals International Inc. (Laval Quebec) is in advanced talks to sell a big stomach-drug business to Japan’s Takeda Pharmaceutical Co. for about $10 billion, a move seen easing pressure on Valeant over its… Read more »